BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Ovarian cancer AND PDGFRB, JTK12, 5159, P09619, ENSG00000113721, PDGF-R-beta, PDGFR1, CD140B, PDGFR, CD140b AND Prognosis
8 results:

  • 1. An angiogenic tumor phenotype predicts poor prognosis in ovarian cancer.
    Wieser V; Tsibulak I; Reimer DU; Zeimet AG; Fiegl H; Hackl H; Marth C
    Gynecol Oncol; 2023 Mar; 170():290-299. PubMed ID: 36758419
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. The expression of Platelet-derived Growth factor receptors (pdgfrs) and their correlation with overall survival of patients with ovarian cancer.
    Szubert S; Moszynski R; Szpurek D; Romaniuk B; Sajdak S; Nowicki M; Michalak S
    Ginekol Pol; 2019; 90(5):242-249. PubMed ID: 30977516
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. PDGF-AA mediates mesenchymal stromal cell chemotaxis to the head and neck squamous cell carcinoma tumor microenvironment.
    Watts TL; Cui R; Szaniszlo P; Resto VA; Powell DW; Pinchuk IV
    J Transl Med; 2016 Dec; 14(1):337. PubMed ID: 27931212
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Perivascular pdgfr-β is an independent marker for prognosis in renal cell carcinoma.
    Frödin M; Mezheyeuski A; Corvigno S; Harmenberg U; Sandström P; Egevad L; Johansson M; Östman A
    Br J Cancer; 2017 Jan; 116(2):195-201. PubMed ID: 27931046
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. The Relationship between Intraoperative Rupture and Recurrence of Pediatric ovarian Neoplasms: Preliminary Observations.
    Yousef Y; Pucci V; Emil S
    J Pediatr Adolesc Gynecol; 2016 Apr; 29(2):111-6. PubMed ID: 26300232
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Platelet-derived growth factor receptor beta serum concentrations during first-line therapy in ovarian cancer.
    Mathey S; Graeser MK; Zu Eulenburg C; Woelber L; Trillsch F; Jaenicke F; Müller V; Milde-Langosch K; Mahner S
    Oncology; 2013; 85(2):69-77. PubMed ID: 23860180
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. The PACOVAR-trial: a phase I/II study of pazopanib (GW786034) and cyclophosphamide in patients with platinum-resistant recurrent, pre-treated ovarian cancer.
    Eichbaum M; Mayer C; Eickhoff R; Bischofs E; Gebauer G; Fehm T; Lenz F; Fricke HC; Solomayer E; Fersis N; Schmidt M; Wallwiener M; Schneeweiss A; Sohn C
    BMC Cancer; 2011 Oct; 11():453. PubMed ID: 22014006
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Microinvasive cervical adenocarcinoma (FIGO stage 1A tumors): results of surgical staging and outcome analysis.
    Ceballos KM; Shaw D; Daya D
    Am J Surg Pathol; 2006 Mar; 30(3):370-4. PubMed ID: 16538058
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.